676259-46-4

Upstream product

• 14104-20-2 silver tetrafluoroborate 
• 654670-48-1 [Pd(μ-(N-(2-mercaptoethyl)-3,5-dimethylpyrazole(1-)))Cl]2 
• 6737-42-4 1,3-bis-(diphenylphosphino)propane 
• 75-05-8 acetonitrile 

Downstream Products

• 676259-50-0 [Pd2(μ-(N-(2-mercaptoethyl)-3,5-dimethylpyrazole(1-)))2(1,3-bis(diphenylphosphino)propane)](2+) 

Relevant academic research and scientific papers

Reactivity of [PdCl(μ-med)]2 with monodentate or bidentate ligands. Structure of the dinuclear complexes [Pd(μ-med)(PPh 3)]2(BF4)2 and [Pd(μ-med)(bpy)] 2(BF4)2. [Hmed=N-(2-mercaptoethyl)-3,5- dimethylpyrazole]

Treatment of the ligand N-(2-mercaptoethyl)-3,5-dimethylpyrazole with [Pd(CH3COO)2]3 and reaction of [PdCl(μ-med)]2 with pyridine (py) or triphenylphosphine (PPh 3) in the presence of AgBF4 produced the following complexes: [Pd(CH3COO)(μ-med)]2, [Pd(μ-med)(py)] 2(BF4)2 and [Pd(μ-med)(PPh 3)]2(BF4)2. Similar reactions carried out with 2,2′-bipyridine (bpy) or 1,3-bis(diphenylphosphino) propane (dppp) produced [Pd(μ-med)(bpy)]x(BF4) x (x=1 or 2) and [Pd(μ-med)(dppp)]x(BF 4)x (x=1 or 2). Treatment of [Pd(μ-med)(bpy)] x(BF4)x with [PdCl2(CH 3CN)2] produced [Pd3Cl2(μ-med) 2(bpy)2](BF4)2. Treatment of [Pd(μ-med)(dppp)]x(BF4)x with [PdCl 2(CH3CN)2] produced a mixture of [Pd(μ-Cl)(dppp)]2(BF4)2 and [Pd(μ-med)2(dppp)]2+. X-ray crystal structures of [Pd(μ-med)(PPh3)]2(BF4) 2·2CH3CN and [Pd(μ-med)(bpy)]2(BF 4)2·0.5CH3OH are presented.